Cargando…

Establishing a Rodent Model of Ventricular Fibrillation Cardiac Arrest With Graded Histologic and Neurologic Damage With Different Cardiac Arrest Durations

PURPOSE: The aim of the study was to establish a ventricular fibrillation (VF) cardiac arrest (CA) resuscitation model with consistent neurologic and neuropathologic damage as potential therapeutic target. METHODS: Prospectively randomized groups of experiments in two phases. In phase 1 four groups...

Descripción completa

Detalles Bibliográficos
Autores principales: Ettl, Florian, Magnet, Ingrid A.M., Weihs, Wolfgang, Warenits, Alexandra-Maria, Grassmann, Daniel, Wagner, Michael, Teubenbacher, Ursula, Högler, Sandra, Sterz, Fritz, Janata, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039375/
https://www.ncbi.nlm.nih.gov/pubmed/28968287
http://dx.doi.org/10.1097/SHK.0000000000001004
_version_ 1783338660298489856
author Ettl, Florian
Magnet, Ingrid A.M.
Weihs, Wolfgang
Warenits, Alexandra-Maria
Grassmann, Daniel
Wagner, Michael
Teubenbacher, Ursula
Högler, Sandra
Sterz, Fritz
Janata, Andreas
author_facet Ettl, Florian
Magnet, Ingrid A.M.
Weihs, Wolfgang
Warenits, Alexandra-Maria
Grassmann, Daniel
Wagner, Michael
Teubenbacher, Ursula
Högler, Sandra
Sterz, Fritz
Janata, Andreas
author_sort Ettl, Florian
collection PubMed
description PURPOSE: The aim of the study was to establish a ventricular fibrillation (VF) cardiac arrest (CA) resuscitation model with consistent neurologic and neuropathologic damage as potential therapeutic target. METHODS: Prospectively randomized groups of experiments in two phases. In phase 1 four groups of male Sprague–Dawley rats (n = 5) were resuscitated after 6 min VFCA with 2 and 6 min basic life support durations (BLS) with and without adrenaline. In phase 2 the most promising group regarding return of spontaneous circulation (ROSC) and survival was compared with a group of 8 min CA. Resuscitability, neurologic deficit scores (NDS), and overall performance category (OPC) were assessed daily; histolopathology of the hippocampal CA1 region [hematoxylin and eosin- (viable neurons), Fluoro-Jade- (dying neurons), and Iba-1 immunostaining (microglial activation–semiquantitative)] on day 14. RESULTS: Two minutes BLS and with adrenaline as most promising group of phase 1 compared with an 8 min group in phase 2 exhibited ROSC in 8 (80%) vs. 9 (82%) animals and survivors till day 14 in 7 (88%) (all OPC 1, NDS 0 ± 0) vs. 6 (67%) (5 OPC 1, 1 OPC 2, NDS 0.83 ± 2.4) animals. OPC and NDS were only significantly different at day 1 (OPC: P = 0.035; NDS: P = 0.003). Histopathologic results between groups were not significantly different; however, a smaller variance of extent of lesions was found in the 8 min group. Both CA durations caused graded neurologic, overall, such as histopathologic damage. CONCLUSIONS: This dynamic global ischemia model offers the possibility to evaluate further cognitive and novel neuroprotective therapy testing after CA.
format Online
Article
Text
id pubmed-6039375
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-60393752018-07-20 Establishing a Rodent Model of Ventricular Fibrillation Cardiac Arrest With Graded Histologic and Neurologic Damage With Different Cardiac Arrest Durations Ettl, Florian Magnet, Ingrid A.M. Weihs, Wolfgang Warenits, Alexandra-Maria Grassmann, Daniel Wagner, Michael Teubenbacher, Ursula Högler, Sandra Sterz, Fritz Janata, Andreas Shock Basic Science Aspects PURPOSE: The aim of the study was to establish a ventricular fibrillation (VF) cardiac arrest (CA) resuscitation model with consistent neurologic and neuropathologic damage as potential therapeutic target. METHODS: Prospectively randomized groups of experiments in two phases. In phase 1 four groups of male Sprague–Dawley rats (n = 5) were resuscitated after 6 min VFCA with 2 and 6 min basic life support durations (BLS) with and without adrenaline. In phase 2 the most promising group regarding return of spontaneous circulation (ROSC) and survival was compared with a group of 8 min CA. Resuscitability, neurologic deficit scores (NDS), and overall performance category (OPC) were assessed daily; histolopathology of the hippocampal CA1 region [hematoxylin and eosin- (viable neurons), Fluoro-Jade- (dying neurons), and Iba-1 immunostaining (microglial activation–semiquantitative)] on day 14. RESULTS: Two minutes BLS and with adrenaline as most promising group of phase 1 compared with an 8 min group in phase 2 exhibited ROSC in 8 (80%) vs. 9 (82%) animals and survivors till day 14 in 7 (88%) (all OPC 1, NDS 0 ± 0) vs. 6 (67%) (5 OPC 1, 1 OPC 2, NDS 0.83 ± 2.4) animals. OPC and NDS were only significantly different at day 1 (OPC: P = 0.035; NDS: P = 0.003). Histopathologic results between groups were not significantly different; however, a smaller variance of extent of lesions was found in the 8 min group. Both CA durations caused graded neurologic, overall, such as histopathologic damage. CONCLUSIONS: This dynamic global ischemia model offers the possibility to evaluate further cognitive and novel neuroprotective therapy testing after CA. Lippincott Williams & Wilkins 2018-08 2018-07-13 /pmc/articles/PMC6039375/ /pubmed/28968287 http://dx.doi.org/10.1097/SHK.0000000000001004 Text en Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Shock Society. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Basic Science Aspects
Ettl, Florian
Magnet, Ingrid A.M.
Weihs, Wolfgang
Warenits, Alexandra-Maria
Grassmann, Daniel
Wagner, Michael
Teubenbacher, Ursula
Högler, Sandra
Sterz, Fritz
Janata, Andreas
Establishing a Rodent Model of Ventricular Fibrillation Cardiac Arrest With Graded Histologic and Neurologic Damage With Different Cardiac Arrest Durations
title Establishing a Rodent Model of Ventricular Fibrillation Cardiac Arrest With Graded Histologic and Neurologic Damage With Different Cardiac Arrest Durations
title_full Establishing a Rodent Model of Ventricular Fibrillation Cardiac Arrest With Graded Histologic and Neurologic Damage With Different Cardiac Arrest Durations
title_fullStr Establishing a Rodent Model of Ventricular Fibrillation Cardiac Arrest With Graded Histologic and Neurologic Damage With Different Cardiac Arrest Durations
title_full_unstemmed Establishing a Rodent Model of Ventricular Fibrillation Cardiac Arrest With Graded Histologic and Neurologic Damage With Different Cardiac Arrest Durations
title_short Establishing a Rodent Model of Ventricular Fibrillation Cardiac Arrest With Graded Histologic and Neurologic Damage With Different Cardiac Arrest Durations
title_sort establishing a rodent model of ventricular fibrillation cardiac arrest with graded histologic and neurologic damage with different cardiac arrest durations
topic Basic Science Aspects
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039375/
https://www.ncbi.nlm.nih.gov/pubmed/28968287
http://dx.doi.org/10.1097/SHK.0000000000001004
work_keys_str_mv AT ettlflorian establishingarodentmodelofventricularfibrillationcardiacarrestwithgradedhistologicandneurologicdamagewithdifferentcardiacarrestdurations
AT magnetingridam establishingarodentmodelofventricularfibrillationcardiacarrestwithgradedhistologicandneurologicdamagewithdifferentcardiacarrestdurations
AT weihswolfgang establishingarodentmodelofventricularfibrillationcardiacarrestwithgradedhistologicandneurologicdamagewithdifferentcardiacarrestdurations
AT warenitsalexandramaria establishingarodentmodelofventricularfibrillationcardiacarrestwithgradedhistologicandneurologicdamagewithdifferentcardiacarrestdurations
AT grassmanndaniel establishingarodentmodelofventricularfibrillationcardiacarrestwithgradedhistologicandneurologicdamagewithdifferentcardiacarrestdurations
AT wagnermichael establishingarodentmodelofventricularfibrillationcardiacarrestwithgradedhistologicandneurologicdamagewithdifferentcardiacarrestdurations
AT teubenbacherursula establishingarodentmodelofventricularfibrillationcardiacarrestwithgradedhistologicandneurologicdamagewithdifferentcardiacarrestdurations
AT hoglersandra establishingarodentmodelofventricularfibrillationcardiacarrestwithgradedhistologicandneurologicdamagewithdifferentcardiacarrestdurations
AT sterzfritz establishingarodentmodelofventricularfibrillationcardiacarrestwithgradedhistologicandneurologicdamagewithdifferentcardiacarrestdurations
AT janataandreas establishingarodentmodelofventricularfibrillationcardiacarrestwithgradedhistologicandneurologicdamagewithdifferentcardiacarrestdurations